Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a post on X about a paper by Navneet Singh et al. published in JCO Oncology Practice:
“Stage III non–small cell lung cancer (NSCLC) is a highly heterogeneous disease requiring a multidisciplinary approach.
Recent ASCO recommendations highlight this complexity!”
Authors: Navneet Singh, Martin Früh, Matthew Gubens, Nofisat Ismaila, Megan Daly.
More posts featuring Elvina Almuradova.
